rss
Evid Based Nurs 9:84 doi:10.1136/ebn.9.3.84
  • Treatment

Oestrogen and progestin increased urge and stress incontinence in postmenopausal women with coronary heart disease


 
 Q In postmenopausal women with coronary heart disease, does oestrogen and progestin treatment affect the risk of stress and urge urinary incontinence (UI)?

METHODS

GraphicDesign:

secondary analysis of a randomised placebo controlled trial (Heart Estrogen/progestin Replacement Study [HERS]).

GraphicAllocation:

{concealed}.*

GraphicBlinding:

blinded {patients, investigators, and outcome assessors}.*

GraphicFollow up period:

4–48 months.

GraphicSetting:

20 clinical centres in the US.

GraphicPatients:

1228 postmenopausal women <80 years of age who had coronary heart disease, an intact uterus, and reported no episodes of UI within the past week. {Exclusion criteria included use of oral, parenteral, vaginal, or transdermal hormones within 3 months; intolerance to hormone therapy; fasting blood sugar concentration ⩾300 mg/dl; serum triglyceride concentration ⩾300 mg/dl; serum glutamic oxaloacetic transaminase >1.2 times normal; history of …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article